T-Medical Group Inc. Signs Letter of Intent to Buy Telaleaf Health Inc.
Summary
New York, NY, November 21, 2023 --( PR.com )-- T-Medical Group Inc., a leading provider of medical technology solutions, today announced that it has signed a letter of intent to acquire Telaleaf Health Inc., a privately held Canadian company that develops and markets innovative software solutions for the healthcare industry and owns a wholly owned subsidiary Telaleaf Health GmbH, a German telemedicine company, that specializes in the fast-growing European Cannabis market.Under the terms of the agreement, T-Medical Group will purchase all the outstanding shares of Telaleaf for a purchase price of forty-five million (45,000,000) common shares of T-Medical. "The acquisition of Telaleaf is a significant step forward in our strategy to expand our multinational portfolio of healthcare software solutions," said Dominick Bianco, Director of T-Medical Group. "Gavin Treanor, CEO of Telaleaf, added, "We are excited to join forces with T-Medical Group Inc., a leading provider of medical technology solutions. We believe that our combined expertise and resources will allow us to accelerate the development and commercialization of our innovative software solutions, and to better serve our customers. The companys products and services are designed to improve value, access and quality of patient outcomes.